2,343 reports of this reaction
3.2% of all HUMAN IMMUNOGLOBULIN G reports
#2 most reported adverse reaction
FATIGUE is the #2 most commonly reported adverse reaction for HUMAN IMMUNOGLOBULIN G, manufactured by ADMA Biologics, Inc.. There are 2,343 FDA adverse event reports linking HUMAN IMMUNOGLOBULIN G to FATIGUE. This represents approximately 3.2% of all 73,013 adverse event reports for this drug.
Patients taking HUMAN IMMUNOGLOBULIN G who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among HUMAN IMMUNOGLOBULIN G users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for HUMAN IMMUNOGLOBULIN G:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,343 FDA reports for HUMAN IMMUNOGLOBULIN G. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 3.2% of all adverse event reports for HUMAN IMMUNOGLOBULIN G, making it one of the most commonly reported side effect.
If you experience fatigue while taking HUMAN IMMUNOGLOBULIN G, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.